Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579)
Virginia G. Kaklamani, Jacqueline S. Jeruss, Elisha Hughes, Kalliopi Siziopikou, Kirsten M. Timms, Alexander Gutin, Victor Abkevich, Zaina Sangale, Cara Solimeno, Krystal L. Brown, Joshua Jones, Anne Renee Hartman, Caitlin Meservey, Borko Jovanovic, Irene Helenowski, Seema A. Khan, Kevin Bethke, Nora Hansen, Regina Uthe, Sara GiordanoSteven Rosen, Kent Hoskins, Jamie Von Roenn, Sarika Jain, Vamsi Parini, William Gradishar
Dive into the research topics of 'Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579)'. Together they form a unique fingerprint.